-
My Account
In App
My Account
BSE Live
Dec 04, 16:01Prev. Close
38.36
Open Price
38.99
Bid Price (Qty.)
39.35 (1000)
Offer Price (Qty.)
39.90 (15754)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.27 | -0.76 | -2.93 | 2.05 | 0.68 | |
| Net CashFlow From Operating Activities | -2.03 | -2.90 | 10.44 | -7.14 | 1.64 | |
| Net Cash Used In Investing Activities | 0.73 | -10.16 | -11.18 | 1.70 | 0.06 | |
| Net Cash Used From Financing Activities | 1.38 | -18.43 | 0.78 | 5.25 | -1.63 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.08 | -31.49 | 0.04 | -0.20 | 0.07 | |
| Cash And Cash Equivalents Begin of Year | 0.51 | -4.94 | 0.04 | 0.24 | 0.17 | |
| Cash And Cash Equivalents End Of Year | 0.59 | -36.43 | 0.08 | 0.04 | 0.24 |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y
